Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Menveo Vaccine

Prescription Icon
Prescription Required

Marketer

GlaxoSmithKline Consumer Healthcare

Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135) (NA)

Overview Menveo Vaccine

Meningococcal disease prevention is achieved through Menveo vaccination. This vaccine actively immunizes against invasive disease caused by *Neisseria meningitidis* serogroups A, C, Y, and W-135. Recommended for infants (from two months), children, adolescents, and adults, Menveo's administration should always follow official guidelines. Professional healthcare providers administer this vaccine; self-injection is strictly prohibited. Completing the entire vaccination course is crucial for optimal protection. Commonly reported side effects include injection site discomfort (pain, swelling, redness), nausea, headache, drowsiness, fretfulness, general malaise, and muscle aches. Persistent or worsening side effects warrant immediate medical attention; your physician can offer strategies for symptom management. Prior to vaccination, disclose any existing health conditions or medications to your doctor to ensure safety. Pregnant or breastfeeding individuals should consult their physician before vaccination.

Uses of Menveo Vaccine

Averting meningococcal infection

Major Benefits of Menveo Vaccine:

Your healthcare provider will instruct you on the proper administration of this medication.

Common Side effects of Menveo Vaccine:

  • Injection site reaction
  • Sleepiness
  • Nausea
  • Headache
  • Irritation
  • Muscle pain

How to use Menveo Vaccine:

Your healthcare provider will instruct you on the proper administration of this medication.

How Menveo Vaccine works:

Menveo vaccination triggers the body's immune response, mimicking a minor infection without causing disease. This process prompts the production of protective antibodies, preparing the body to defend against subsequent exposures to the targeted pathogens.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Menveo vaccination lacks established safety data. Seek medical advice before combining them.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Menveo Vaccine during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human trials are currently scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Menveo Vaccine safely. Available data from human studies indicate minimal risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Menveo vaccination.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Menveo Vaccine administration to individuals with renal impairment. Physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Menveo Vaccine in individuals with liver conditions appears safe. Preliminary findings indicate that altering the vaccine dosage for these patients may be unnecessary. Physician consultation is advised.

What if you forget to take Menveo Vaccine :

Should you forget a scheduled Menveo vaccination, seek your physician's advice.

Facts to Know About Menveo Vaccine

LabelValue
Chemical Category Immunizations
Developing Habits No.
Treatment Category Immunizations

FAQs on Menveo Vaccine

Menveo Vaccine protects against invasive meningococcal disease caused by serogroups A, C, Y, and W-135 in individuals aged 2 months to 55 years.
Menveo Vaccine is contraindicated in patients with a known allergy to its components or similar medications. Allergic reactions can manifest as rash, breathing difficulty, or facial/tongue swelling. Report any prior medication allergies to your doctor.
Individuals aged 15-55 at continued risk of meningococcal disease may receive a single Menveo booster dose at least four years after their previous dose. Consult your doctor if you have questions.
Menveo vaccination must be administered by a qualified healthcare professional (doctor or nurse) and is not for self-injection. It's typically injected into the upper arm muscle, though the thigh muscle may be used for children. Always follow your doctor's instructions for optimal results.
No, the Menveo vaccine cannot cause meningococcal disease. It trains your immune system to produce protective antibodies, enabling your body to fight off the infection should you encounter it.
Menveo Vaccine
3,529
MRP 4,299
17% off